Resilience Care Expands Oncology Telemonitoring Deployment With Ramsay Santé

According to a recent LinkedIn post from Resilience Care, the company is continuing its collaboration with healthcare provider Ramsay Santé to expand the use of medical telemonitoring in oncology care. The post indicates that, since 2022, the two organizations have been working toward making remote monitoring a durable component of cancer patient management and a new standard of care.

The LinkedIn post highlights that this collaboration now reportedly involves the deployment of telemonitoring solutions across 22 Ramsay Santé clinics in France, with more than 2,200 cancer patients on average being monitored and supported each month. Usage data cited in the post are said to show strong patient uptake of the system and effective integration into clinical workflows. The post attributes this traction to Ramsay Santé’s willingness to leverage digital tools to improve patient care and quality of life, the strong engagement of medical and paramedical teams, multidisciplinary care models that link nurses and physicians, and on-the-ground support from Resilience Care experts to facilitate implementation in care pathways.

For investors, the described scale-up suggests growing commercial adoption of Resilience Care’s telemonitoring platform within a major healthcare group, potentially supporting recurring usage-based revenue and reinforcing the company’s positioning in digital oncology care. Broad integration across multiple clinics and positive user metrics, if sustained, could strengthen Resilience Care’s value proposition in discussions with other hospital networks and payers, and may provide a reference model for wider deployment of remote monitoring in oncology. More broadly, the collaboration points to continued digitalization of cancer care delivery in France, in which Resilience Care appears to be positioning itself as an enabling technology partner.